January 2010 Updates

* Read the January 2010 MAPS Email Newsletter in the MAPS email news archive * December 17, 2010: Eighth Subject Enrolled in LSD Trial The eighth subject has been enrolled in the MAPS-sponsored clinical …

Peyote Neuropsychological Study

Investigator: John Halpern, MD, Harrison Pope, MD Harvard Medical School – Cambridge, Massachussetts Contact: Sponsor: Heffter, NIDA, Harvard Medical School, MAPS Investigators have begun neuropsychological …

Psychedelic Review Archives 1963-1971

Psychedelic Review,Vol. I, No. 1, June 1963 (complete pdf) Editorial Statement of Purpose “Can This Drug Enlarge Man’s Mind?”, Gerald Heard The Subjective After-Effects of Psychedelic …

LSD and Psilocybin Related Documents and Resources

Click here to access the investigator’s brochure (or “IB”) for psilocybin commissioned by MAPS and intended to be submitted to FDA and institutional review boards or ethics boards. The IB …

For Information

For information about currently ongoing psilocybin research by the Heffter Research Institute, visit heffter.org.

Generous Donations

Generous donations have been made by Robert Barnhart ($125,000), Kevin Herbert ($18,750), Vanja Palmers ($10,000), Fredi Muller (10,000 SF), Amanda Feilding/Beckley Foundation (5000 Euros), and Anonymous …

Three Letters: Ecstasy and Parkinsonism

Three letters in response to O'Suilleabhain and Giller 2003 and Kish 2003 Movement Disorders; Published On-line Sept 13, 2004 Letter #1 DOI: 10.1002/mds.20223 Ecstasy Use-Parkinson's Disease Link Tenuous …